Navigation Links
New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
Date:11/14/2007

atal screening fails mainly in children with duct-dependent systemic circulation.

Granelli and Ostman-Smith conducted single pre- and postductal measurements of PI using the Masimo Radical SET Pulse Oximeter in a total of 10,000 healthy newborns (ranging in age from 1 hour to five days) and established PI reference values of healthy babies. In establishing reference values that validate possible PI indices for normal vs. disease state in newborns, researchers were able to show that low PI values may correspond to illness.

Study results showed that combined neonatal examination and oxygen saturation screening detected only 78% of the newborns with LHOD, but when PI was added, 100% of all newborns with LHOD showed abnormalities -- indicating that PI may reflect abnormal blood flow from the heart in CHD newborns. All LHOD newborns had either pre- or postductal PI values below the interquartile cut-off value of 1.18 and five had values below a potential cut-off of 0.70, leading researchers to conclude that "PI values lower than 0.70 may indicate illness and a value less than 0.50 indicates definite underperfusion."

Study findings suggest that a combination of saturation screening cut-offs with PI value cut-offs may help improve the early detection of congenital heart defects that have duct-dependent systemic circulation. As a result, researchers concluded that PI is a "promising tool for improving the detection of critical congenital heart disease with duct-dependent systemic circulation."(1)

Joe E. Kiani, Chairman and CEO of Masimo stated, "When we introduced Masimo SET ten years ago, we knew that the improved accuracy and fidelity would allow clinicians to more tightly control the arterial oxygen levels of their patients, but it is truly remarkable to see research like this where our technology is being used to improve screening for congenital heart defects. We are all indebted to clinicians like these from Gothenburg University who are constan
'/>"/>

SOURCE Masimo Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...October 7 /-,Sosei Group Co...ectura,Group plc ("Vectura"; LSE: VEC), announce r...cacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data sh...nhaled long-acting muscarinic antagonist (LAMA), p...
(Date:10/6/2008)...wswire/ -- "A return to the use of,chimpanzees in ...cientific,justification," according to a paper rel...ory Animals (ATLA). "An Assessment of the Role of,...at vaccine responses in,chimpanzees are not predic...impanzees, critical role and importance in AIDS va...
(Date:10/6/2008)... children, parents discussing clinical ...6 /PRNewswire-USNewswire/ -- From asthma and cance...es lives and improves their,health and well-being....alth (NIH), "Children and Clinical Studies", (http... offers parents and health,care providers an insid...
(Date:10/6/2008)...with Durezol Dosed Prior to Surgery, TAMPA, Fla.,... a,privately held ophthalmic-focused biopharmaceut...fluprednate ophthalmic emulsion) 0.05% is now,comm... the U.S. Food and,Drug Administration in June 200...d for the treatment of inflammation and pain assoc...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5VioQuest Pharmaceuticals Inc Valuation Upgrade Review Issued By Scimitar Equity LLC 6779 1VioQuest Pharmaceuticals Inc Valuation Upgrade Review Issued By Scimitar Equity LLC 6779 2Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony 28TM 29 Transdermal Continuous Glucose Monitoring System in Patients 2729 1Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony 28TM 29 Transdermal Continuous Glucose Monitoring System in Patients 2729 2Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony 28TM 29 Transdermal Continuous Glucose Monitoring System in Patients 2729 3Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony 28TM 29 Transdermal Continuous Glucose Monitoring System in Patients 2729 4Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 1Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 2Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 3Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 4Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 5Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 6Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results 6772 7CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011 vcMMAE 2728 1CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011 vcMMAE 2728 2CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011 vcMMAE 2728 3CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011 vcMMAE 2728 4CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011 vcMMAE 2728 5
...WIRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIAC) ...hief Executive Officer of ViaCell, will present an...eline at the C.E. Unterberg,Towbin Emerging Growt...07 at 3:00 p.m. at the Mandarin Oriental Hotel in ...tion will be available on,the Investor Information...
..., July 10, 2007 /CNW/ - Protox,Therapeutics Inc. (...lts from its Phase 1 clinical trial evaluating ,PR...e cancer,following radiation failure. The trial r...rated and shows promising signs,of therapeutic act...t. , ,"The completion of the PRX302 Phase 1 ...
Other Medicine Technology:Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5
(Date:10/7/2008)...RNewswire-FirstCall/ -- Stallergenes S.A.,today an...greement with,Catalent for the promotion and distr...FLEX(R), co-developed and co-manufactured by Catal...sts of a syringe pre-filled with adrenaline, which....3 and 0.15 mg), in an,autoinjector device. The Me...
(Date:10/7/2008)...of asthma in a young child may well be more challe..., according to a review of research and clinical e... Indiana University School of Medicine and Riley H... issue of Clinical Pediatrics . , "Wheezing ca... Professor of Pediatrics at the IU School of Medic...
(Date:10/7/2008)...rial Specialties, Mfg. is pleased to announce the ...hese filters are exclusively available from Indust... push-to-connect style fittings integrated into th...ne filter offers versatility and customization for... (PRWEB) October 7, 2008 -- Exclusively availa...
(Date:10/6/2008)...fight against childhood obesity, researcher notes ... Three-quarters of middle schools have vending mac...new study finds. , The research demonstrates th...ls, and "that those vending machines don,t always ...y Virus, a registered dietitian with the Center fo...
Breaking Medicine News(10 mins):Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:Wheezing and asthma in young children 2Health News:Vending Machines Found in Most Middle Schools 2
India, Pakistan Teams To Inaugurate Inzy's Hospital
... been found through an animal study that Aspartame...ut that drinking four to five 20-ounce bottles of ...be the //cause of cancers. The study would be pub...ironmental Health Perspectives, an US government-r...
...East Asia has been long considered a wonderland fo...otel lobbies or restaurants without any inhibition...vernment is seriously thinking about imposing a sm...bars. In Malaysia and Thailand, smoking bans alre...
...attempting to learn a new task, taking short break...easy, according to a new study conducted by Massac...d Foster and Matthew Wilson, working at the Massac...bridge, found that rats' brains 'replay' their exp...
Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2Health News:Task Learning Made Simple By Taking Short Breaks 2
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed.
The Neuroclip is designed for safe, quick, and stable fixation of cranial bone flaps. Application is simple with minimal instrumentation. The Neuroclip can be applied to the cranial bone flap while t
Lorenz 1.0 mm titanium system provides a rigid fixation alternative for areas with high palpability and prominent bone formation. These areas include the frontal bone and the areas surrounding the or
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery.
Medicine Products: